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Abstract: The editors introduce the Biomedical Optics Express feature 
issue on “Phantoms for the Performance Evaluation and Validation of 
Optical Medical Imaging Devices.” This topic was the focus of a technical 
workshop that was held on November 7–8, 2011, in Washington, D.C. The 
feature issue includes 13 contributions from workshop attendees. 
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The impetus of the clinical applications of optical medical imaging technologies has become 
critical in recent years. One of the key advantages of the optical imaging approach is its 
minimal invasiveness, which allows for safe practices and enables progressive in vivo optical 
diagnostics and treatment [1–12]. The large variability in key tissue optical properties, such as 
refractive index, scattering coefficient, and absorption coefficient, in biological media has 
been of major interest for achieving reliable diagnoses of disease and for quantifying specific 
features in the tissues [13–18]. In addition, recent studies have demonstrated that many optical 
imaging modalities are complementary to conventional radiation imaging techniques. 
Therefore, multimodal approaches combining optical and radiological imaging techniques 
have been explored [19–21]. 
 
Fig. 1. Translational research map of medical devices from the basic research state to practical 
application in clinical settings. 
As illustrated in the translational research map in Fig. 1, optical medical imaging devices 
are initially developed in basic research fields, mostly in academia, in order to perform proof-
of-principle experiments, designing prototypes for conceptualization of the imaging 
capability, and testing the feasibility of the measurement concepts. Advancing optical medical 
imaging technologies from concept to reality requires characterization, calibration, and 
validation tools [22,23]. These tools would include artifacts or virtual tissue standards (known 
as “phantoms”) that test and optimize hardware, software, and applications; provide training 
to users; and ensure comparability of measurements across instruments and institutions [24–
26]. 
The phantoms are “materials or artifacts that are used to test and evaluate the 
measurement performance of different measuring systems for specific tasks,”  and their 
specific properties may vary depending on their use, such as device validation and inter-
laboratory comparisons [27]. In other words, in addition to their primary use for proof-of-
principle studies, phantoms are used for benchmarking system performance and ensuring data 
consistency across multiple instruments and even vendors. In general, the application-
dependent properties of the ideal phantoms are discussed elsewhere [28]. Phantoms used for 
regulatory clearance and quality assurance during clinical trials and field use will have to be 
fabricated to the same quality as the biomedical optical devices they are serving. In addition, 
their physical properties will have to be accurately known, and, for the most effective 
quantitative applications, they may be traceable to the international system (SI) of units [29]. 
On November 7–8, 2011, in Washington D.C., The Catholic University of America, with 
the support of the National Institute of Standards and Technology, hosted a workshop on 
“standards for phantoms for the performance evaluation and validation of optical medical 
imaging devices.” During this workshop, 20 invited speakers gave technical presentations to 
address measurement challenges in quantitative optical medical imaging and the use of 
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discussions focused on the use of phantoms for standards in optical coherence tomography 
and in reflectance/transmission mode spectroscopic imaging technologies: (1) to achieve 
measurement standards in optical medical imaging devices and potential incorporation of 
phantom-based test methods into biophotonic imaging standards and FDA guidance 
documents (Jeeseong Hwang, Albert Cerussi, Joshua Pfefer, and Bruce Drum); (2) to resolve 
measurement challenges towards quantitative clinical applications of optical imaging devices 
(Guillermo Tearney, Jessica Ramella-Roman, Ron Xu, David Allen, Joseph Rice, Edward 
Livingston, and Maritoni Litorja); (3) to overcome barriers and take opportunities towards 
standards with ideal phantoms (Pete Tomlins, Steve Jacques, Irving Bigio, Elizabeth Hillman, 
Jean-Pierre Bouchard, and Guy Lamouche). There were also presentations to review recent 
phantom research efforts (“The history of tissue-simulating phantoms” by Brian Pogue and 
“Phantoms and quantitative optical diagnostic imaging” by Scott Prahl) and to address future 
directions (“Phantoms for the future” by Robert Nordstrom) as well. This feature issue of 
Biomedical Optics Express showcases selected contributions made by speakers and attendees 
to this workshop. The key highlights of contributed papers in this feature volume are briefly 
presented below. 
Hyperspectral imaging (HSI) [30,31] has the potential to achieve high spatial resolution 
and high functional sensitivity for noninvasive assessment of oxygen level in cells and tissues 
[32,33]. However, clinical acceptance of hyperspectral imaging in ischemic wound 
assessment is hampered by its poor reproducibility, low accuracy, and misinterpreted biology. 
Ronald Xu et al. have proposed a digital tissue phantom (DTP) platform [34] for quantitative 
calibration and performance evaluation of spectral wound imaging devices. The technical 
feasibility of such a DTP platform was demonstrated by both in vitro and in vivo experiments. 
Samarov  et al.  presented a statistical analysis framework for HSI analysis validation by 
comparing the performance of two algorithms, the Least Absolute Shrinkage and Selection 
Operator (LASSO) [35] and the Spatial LASSO (SPLASSO) [36], extracting the abundance 
fraction of water soluble dyes in mixtures printed on microarray chips that served as HSI test 
phantoms. The design and fabrication of custom-tailored microarrays [37] for use as 
phantoms in the characterization of HSI is described by Clarke et al. In this work, as the shape 
of the dye spots in the array results in significant scattering signals, which can be used to test 
image analysis algorithms, the separation of the scattering signals allows elucidation of 
individual spectra of different dyes. 
In  optical coherence tomography  (OCT) [38,39], Guy Lamouche et al.  reviewed the 
development of OCT phantoms that are capable of mimicking a number of tissue properties 
and discussed durable phantoms that can replicate not only optical properties, but also 
mechanical and structural properties of a range of tissues. Robert Chang et al. reports on a 
novel fabrication approach to build multilayered optical tissue phantoms that serve as 
independently validated test targets for axial resolution and contrast in scattering 
measurements by depth-resolving OCT with general applicability to a variety of three-
dimensional optical sectioning platforms, including confocal microscopy and OCT. Varying 
the dimensions of the scattering microspheres and the thickness of the intervening transparent 
polymer layers enables different spatial frequencies to be realized in the transverse dimension 
of the solid phantoms. Anant Agrawal et al.  have designed, fabricated, and tested a 
nanoparticle-embedded phantom incorporated into a model eye in order to characterize the 
point spread function of retinal OCT devices in three dimensions under realistic imaging 
conditions. This model eye-based phantom can provide retinal OCT device developers and 
users a means to rapidly, objectively, and consistently assess the point spread function, a 
fundamental imaging performance metric [40]. 
For  quantitative evaluation of the wavelength and/or morphology-dependent spectral 
properties, including absorption and reduced scattering coefficients of biological tissue layers 
is important for elucidating light propagation for quantitative optical spectroscopy of tissue 
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trained with radial reflectance data from layered tissue Monte Carlo simulations as an 
approach for broadband measurement of layered mucosal tissue optical properties. As the 
sensitivity to surface profile of noncontact optical imaging techniques leads to incorrect 
measurements of optical properties and consequently physiological parameters, Thu Nguyen 
et al. proposed an experimental method to correct the effect of surface profile on spectral 
images using three-dimensional (3D) phantoms of semi-identical shape constructed using an 
inexpensive 3D printer. 
Steven Jacques et al. demonstrated that a reflectance confocal scanning laser microscopy 
measures the decay of reflected signal as the focus moves deeper into solutions of 
nanoparticles, absorbing and scattering materials, and typical reflectance standards. These 
results are mapped into the scattering coefficient and anisotropy of scattering, providing a 
new approach for  measuring tissue optical properties using confocal microscopy. In 
fluorescence nanoparticle-including optical phantoms for  quantitative molecular imaging 
standards, the optical properties of clustered fluorescent nanoparticles such as quantum dots 
(QDs) are essential to the design of QD-based optical phantoms. In a report by HyeongGon 
Kang et al., controlled assembly of a fixed number of QDs into single clusters and multimodal 
optical characterization and analysis of their dynamical photoluminescence (PL) properties 
enables the long-term evaluation of the optical properties of QDs in a single or a clustered 
state. This study is presented in an effort to guide the design and evaluation of QD-based 
phantom materials [41] for the validation of the PL measurements for quantitative molecular 
imaging in a variety of biomedical applications. 
In phantoms involving fluid materials, as noninvasive biophotonic techniques to measure 
flow in the human vasculature have been developed and employed [42–47], appropriate 
calibration and validation techniques dedicated to these particular measurements have 
recently become important. Long Luu et al. introduce a fast prototyping technique based on 
laser micromachining for the fabrication of dynamic flow phantoms to mimic vasculature 
geometries to accommodate a particular experimental scenario. When using Intralipid 
phantoms and mimicking tissue scattering properties [48], fiber optic reflectance devices may 
be used. Stephen Kanick et al.  investigated the spectral response of specific device 
configurations, and the findings are important in characterizing the response over a set range 
of geometrical perturbations involving device configurations such as fiber size and source-
detector distance. The results show the need to consider the influence of scattering phase 
function when using measurements of Intralipid to either characterize or calibrate a 
reflectance device that collects light close to the source. 
Through active scientific interactions among the stakeholders in the field of optical 
medical imaging, the quality of healthcare could improve. However, the development of 
suitable working standards that can be used in any clinic to ascertain the working order of 
measurement instrumentation are necessary to achieve optimal results. When this 
characterization also addresses natural person-to-person variability of the tissue optical 
properties, a wide range of tissues types are of clinical interest for data collection. With good 
measurement practices facilitated by well-designed phantoms, erroneous sources of variability 
from instruments and measurement protocols can be minimized, isolating the variability of the 
tissue itself, both within and among individuals. Studies in this feature volume address 
important roles of optical phantoms to accelerate realization of optical medical imaging 
techniques in the clinic. 
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